Clinical Trial Update: A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating adjuvant cemiplimab therapy in patients with surgically removed non-small cell lung cancer who have not received prior chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: RECRUITING